Genetic Barcodes Facilitate Competitive Clonal Analyses in Vivo

Human Gene Therapy

Volumn 28, Issue 10, 2017, Pages 926-937

  Aranyossy, Tim ^a   Thielecke, Lars ^b   Glauche, Ingmar ^b   Fehse, Boris ^a   Cornils, Kerstin ^a,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Research Institute Children's Cancer Center   (Germany)

Author keywords

clonal dynamics; competitive murine transplantation model; genetic barcodes; hematopoietic reconstitution; stem cell transplantation

Indexed keywords

LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CARCINOGENESIS; CELL CLONE; CELL POPULATION; CONTROLLED STUDY; DNA BARCODING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; SPLEEN; TISSUE REGENERATION; ANIMAL; BONE MARROW CELL; CLONAL EVOLUTION; CYTOLOGY; GENE EXPRESSION; GENE ORDER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; LENTIVIRUS; METABOLISM; PROMOTER REGION; TRANSGENE;

ANIMALS; BONE MARROW CELLS; CLONAL EVOLUTION; CLONE CELLS; GENE EXPRESSION; GENE ORDER; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; LENTIVIRUS; MICE; PROMOTER REGIONS, GENETIC; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 85030328764     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2017.124     Document Type: Article

References (64)

1. Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002;296:2410-2413.
2. Gaspar HB, Parsley KL, Howe S, et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004;364:2181-2187.
3. Ott MG, Schmidt M, Schwarzwaelder K, et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006;12:401-409.
4. Boztug K, Schmidt M, Schwarzer A, et al. Stemcell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med 2010;363:1918-1927.
5. Mitchell RS, Beitzel BF, Schroder ARW, et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2004;2:e234.
6. Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003;300: 1749-1751.
7. Hacein-Bey-Abina S, Garrigue A, Wang GP, et al. Insertional oncogenesis in 4 patients after retrovirusmediated gene therapy of SCID-X1. J Clin Invest 2008;118:3132-3142.
8. Howe SJ, Mansour MR, Schwarzwaelder K, et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008;118:3143-3150.
9. Braun CJ, Boztug K, Paruzynski A, et al. Gene therapy for Wiskott-Aldrich syndrome-long-term efficacy and genotoxicity. Sci Transl Med 2014;6: 227ra33.
10. Hacein-Bey-Abina S, Pai S-Y, Gaspar HB, et al. A modified c-retrovirus vector for X-linked severe combined immunodeficiency. N Engl J Med 2014; 371:1407-1417.
11. Aiuti A, Biasco L, Scaramuzza S, et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 2013;341: 1233151
12. Biffi A, Montini E, Lorioli L, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 2013;341:1233158.
13. Cavazza A, Moiani A, Mavilio F. Mechanisms of retroviral integration and mutagenesis. Hum Gene Ther 2013;24:119-131.
14. Schröder ARW, Shinn P, Chen H, et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002;110:521-529.
15. Sessa M, Lorioli L, Fumagalli F, et al. Lentiviral haemopoietic stem-cell gene therapy in earlyonset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, Phase 1/2 trial. Lancet 2016;388:476-487.
16. Biasco L, Pellin D, Scala S, et al. In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases. Cell Stem Cell 2016;19:107-119.
17. Modlich U, Navarro S, Zychlinski D, et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 2009;17:1919-1928.
18. Modlich U, Bohne J, Schmidt M, et al. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 2006; 108:2545-2553.
19. Hübner J, Hoseini SS, Suerth JD, et al. Generation of genetically engineered precursor T-cells from human umbilical cord blood using an optimized alpharetroviral vector platform. Mol Ther 2016; 24:1216-1226.
20. Suerth JD, Morgan MA, Kloess S, et al. Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors. J Mol Med (Berl) 2016;94:83-93.
21. Labenski V, Suerth JD, Barczak E, et al. Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes. Biomaterials 2016;97:97-109.
22. Kaufmann KB, Brendel C, Suerth JD, et al. Alpharetroviral vector-mediated gene therapy for XCGD: functional correction and lack of aberrant splicing. Mol Ther 2013;21:648-661.
23. Suerth JD, Maetzig T, Brugman MH, et al. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity. Mol Ther 2012;20: 1022-1032.
24. Suerth JD, Maetzig T, Galla M, et al. Selfinactivating alpharetroviral vectors with a splitpackaging design. J Virol 2010;84:6626-6635.
25. Humphries EH, Temin HM. Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA. J Virol1974;14:531-546
26. Kustikova OS, Baum C, Fehse B. Retroviral integration site analysis in hematopoietic stem cells. Methods Mol Biol 2008;430:255-267.
27. Humphries EH, Glover C, Reichmann ME. Rous sarcoma virus infection of synchronized cells establishes provirus integration during S-phase DNA synthesis prior to cellular division. Proc Natl Acad Sci U S A 1981;78:2601-2605
28. Schmidt M, Schwarzwaelder K, Bartholomae C, et al. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods 2007;4:1051-1057.
29. Bystrykh LV, Verovskaya E, Zwart E, et al. Counting stem cells: methodological constraints. Nat Methods 2012;9:567-574.
30. Gabriel R, Eckenberg R, Paruzynski A, et al. Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med 2009;15:1431-1436.
31. Cornils K, Lange C, Schambach A, et al. Stem cell marking with promotor-deprived self-inactivating retroviral vectors does not lead to induced clonal imbalance. Mol Ther 2009;17:131-143.
32. Cornils K, Bartholomae CC, Thielecke L, et al. Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a c-retroviral LTR vector. Exp Hematol 2013;41: 28-38.e3.
33. Kustikova O, Fehse B, Modlich U, et al. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 2005;308: 1171-1174.
34. Modlich U, Schambach A, Li Z, et al. Murine hematopoietic stem cell transduction using retroviral vectors. In: Baum C, ed. Genetic Modification of Hematopoietic Stem Cells: Methods and Protocols. Totowa, NJ: Humana Press, 2009:23-31.
35. Brugman MH, Suerth JD, Rothe M, et al. Evaluating a ligation-mediated PCR and pyrosequencing method for the detection of clonal contribution in polyclonal retrovirally transduced samples. Hum Gene Ther Methods 2013;24:68-79.
36. Golden JA, Fields-Berry SC, Cepko CL. Construction and characterization of a highly complex retroviral library for lineage analysis. Proc Natl Acad Sci U S A 1995;92:5704-5708.
37. Schepers K, Swart E, van Heijst JWJ, et al. Dissecting T cell lineage relationships by cellular barcoding. J Exp Med 2008;205:2309-2318.
38. Gerrits A, Dykstra B, Kalmykowa OJ, et al. Cellular barcoding tool for clonal analysis in the hematopoietic system. Blood 2010;115:2610-2618.
39. Verovskaya E, Broekhuis MJC, Zwart E, et al. Asymmetry in skeletal distribution of mouse hematopoietic stem cell clones and their equilibration by mobilizing cytokines. J Exp Med 2014; 211:487-497.
40. Verovskaya E, Broekhuis MJC, Zwart E, et al. Heterogeneity of young and aged murine hematopoietic stem cells revealed by quantitative clonal analysis using cellular barcoding. Blood 2013; 122:523-532.
41. Cornils K, Thielecke L, Huser S, et al. Multiplexing clonality: combining RGB marking and genetic barcoding. Nucleic Acids Res 2014;42:e56-e56.
42. Lu R, Neff NF, Quake SR, et al. Tracking single hematopoietic stem cells in vivo using highthroughput sequencing in conjunction with viral genetic barcoding. Nat Biotechnol 2011;29:928-933.
43. Wu C, Li B, Lu R, et al. Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells. Cell Stem Cell 2014;14:486-499.
44. Naik SH, Perie L, Swart E, et al. Diverse and heritable lineage imprinting of early haematopoietic progenitors. Nature 2013;496:229-232.
45. Thielecke L, Aranyossy T, Dahl A, et al. Limitations and challenges of genetic barcode quantification. Sci Rep 2017;7:43249.
46. Schambach A, Bohne J, Chandra S, et al. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol Ther 2006;13:391-400.
47. Kostic C, Chiodini F, Salmon P, et al. Activity analysis of housekeeping promoters using selfinactivating lentiviral vector delivery into the mouse retina. Gene Ther 2003;10:818-821.
48. Modlich U, Kustikova OS, Schmidt M, et al. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis. Blood 2005;105:4235-4246.
49. Li Z, Fehse B, Schiedlmeier B, et al. Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell. Leukemia 2002;16:1655-1663.
50. Weber K, Bartsch U, Stocking C, et al. A multicolor panel of novel lentiviral ''gene ontology'' (LeGO) vectors for functional gene analysis. Mol Ther 2008;16:698-706.
51. Weber K, Thomaschewski M, Benten D, et al. RGB marking with lentiviral vectors for multicolor clonal cell tracking. Nat Protoc 2012;5:839-849.
52. Zhang CC, Lodish HF. Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion. Blood 2005;105:4314-4320.
53. Bystrykh LV, Belderbos ME. Clonal analysis of cells with cellular barcoding: when numbers and sizes matter. Methods Mol Biol 2016;257-284.
54. Dykstra B, Olthof S, Schreuder J, et al. Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J Exp Med 2011;208:2691-2703.
55. Fehse B, Kustikova OS, Bubenheim M, et al. Pois(s)on-it's a question of dose. Gene Ther 2004;11:879-881.
56. Sun J, Ramos A, Chapman B, et al. Clonal dynamics of native haematopoiesis. Nature 2014;514: 322-327.
57. Shannon CE. A mathematical theory of communication. Bell Syst Tech J 1948;27:379-423.
58. Selich A, Daudert J, Hass R, et al. Massive clonal selection and transiently contributing clones during expansion of mesenchymal stem cell cultures revealed by lentiviral RGB-barcode technology. Stem Cells Transl Med2016;5:591-601.
59. Porter SN, Baker LC, Mittelman D, et al. Lentiviral and targeted cellular barcoding reveals ongoing clonal dynamics of cell lines in vitro and in vivo. Genome Biol 2014;15:R75.
60. Benveniste P, Frelin C, Janmohamed S, et al. Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential. Cell Stem Cell 2010;6:48-58.
61. Camargo FD, Chambers SM, Drew E, et al. Hematopoietic stem cells do not engraft with absolute efficiencies. Blood 2006;107:501-507.
62. van der Loo JC, Ploemacher RE. Marrow-and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood1995;85:2598-2606.
63. Mohme M, Maire CL, Riecken K, et al. Optical barcoding for single-clone tracking to study tumor heterogeneity. Mol Ther 2017;25:621-633.
64. Maetzig T, Ruschmann J, Lai CK, et al. A lentiviral fluorescent genetic barcoding system for flow cytometry-based multiplex tracking. Mol Ther 2017;25:606-620.